LEIDOS BIOMEDICAL RESEARCH INC
- Unique Entity ID (UEI)
- HV8BH9BPG8Y9
- Parent company
- LEIDOS HOLDINGS, INC. (UEI ZL41ERXMPAR3)
- Registered address
- FREDERICK, MD, district MD-06
- Other names on record
- FREDERICK SAIC INC; LEIDOS BIOMEDICAL RESEARCH, INC.; SAIC FREDERICK INC; SAIC FREDERICK, INC; SAIC-FREDERICK, INC.
Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.
Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved November 19, 2026.
Which agencies pay this vendor, and where the work is done
Fiscal year 2027: -$1,734,827.98
| Agency | Contract dollars |
|---|---|
| Department of Health and Human Services | -$1,734,827.98 |
USAspending's answer by district did not hold to this vendor alone, so it is not shown.
Fiscal year 2026: $779,394,608.38
| Agency | Contract dollars |
|---|---|
| Department of Health and Human Services | $779,394,608.38 |
| District where the work is done | Contract dollars |
|---|---|
| MD-06April McClain Delaney | $779,394,608.38 |
Largest awards
The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.
| Award | Agency | Where the work is done | Award total | Start |
|---|---|---|---|---|
| HHSN261200800001ETAS::75 0849::TAS OPER OF GOVT R&D GOCO FACILITIES | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $4,811,722,791.25 | Ends September 6, 2024 |
| 75N91020F00003NCI OPERATIONAL TASK ORDER | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $1,775,380,496.13 | Ends September 27, 2024 |
| 75N91025F00016NCI OPERATIONAL TASK ORDER, FY26-FY27 | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $825,985,690.65 | Ends August 30, 2027 |
| 75N91019F00129NCI OPERATIONAL TASK ORDER | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $432,416,291.78 | Ends May 21, 2026 |
| 75N91024F00011NCI FY25 OPERATIONAL TASK ORDER | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $398,925,092.88 | Ends August 30, 2025 |
| 75N91019F00139MD NET | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $181,379,395 | Ends October 31, 2029 |
| 75N91023F00008THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAIDS GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATES TO SUPPORT FOR ADVANCED DEVELOPMENT. | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $173,281,267 | Ends May 31, 2029 |
| 75N91020F00039NIAID COVID-19 ACTIV3 | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $159,121,570 | Ends February 28, 2027 |
| 75N91021F00004ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2) | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $141,656,003 | Ends January 28, 2031 |
| 75N91025F00012NIAID DCR FY26-27 OPERATIONAL TASK ORDER | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $137,656,019 | Ends August 30, 2026 |
| 75N91019F00133FFRDC SPACE MANAGEMENT TASK ORDER (LEASES) | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $126,402,596 | Ends August 30, 2024 |
| 75N91020F00006NIAID VRC | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $121,524,201.88 | Ends August 30, 2024 |
| 75N91021F00013ENABLING NCI CLINICAL & RESEARCH DATA SHARING | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $98,565,258.55 | Ends February 28, 2028 |
| 75N91025F00014NIAID VRC FY26-27 OPERATIONAL TASK ORDER | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $87,806,507 | Ends August 30, 2027 |
| 75N91021F00001CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $79,896,408 | Ends October 31, 2026 |
| 75N91018F00071HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23 | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $72,263,032 | Ends August 31, 2029 |
| 75N91026F00034FUNCTIONAL PRECISION MEDICINE AND RESPONSE ASSAYS | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $72,167,416 | Ends September 28, 2031 |
| 75N91019F00130PROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND MANAGEMENT, REGULATORY MONITORING AND COMPLIANCE, STATISTICAL CONSULTATIO | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $63,059,337.28 | Ends August 30, 2020 |
| 75N91020F00021CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $45,855,926 | Ends August 31, 2030 |
| 75N91020F00030CPTAC BIOSPECIMEN COLLECTION | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $37,727,154 | Ends August 30, 2027 |
| 75N91019F00134FFRDC MOONSHOT PORTFOLIO TASK ORDER | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $33,139,792 | Ends September 30, 2027 |
| 75N91025F00005FY26 FFRDC LEASES | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $28,530,382 | Ends August 30, 2026 |
| 75N91019F00138CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $28,263,054 | Ends March 31, 2031 |
| HHSN26100019IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS ? BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS) | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $27,524,748.20 | Ends September 18, 2021 |
| 75N91024F00027FY24/FY25 FFRDC LEASES OPERATIONAL TASK ORDER | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $27,031,348 | Ends August 30, 2025 |
| 75N91021F00015CORE SUPPORT FOR THE IMMUNE CELL NETWORK | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $26,946,544 | Ends December 31, 2027 |
| 75N91022F00013NIAID-VRC-MRNA VACCINE CAPABILITY ESTABLISHMENT | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $25,098,522 | Ends June 17, 2030 |
| 75N91022F00019DISCOVERY AND DEVELOPMENT OF CANCER THERAPEUTICS FOR NEXT PROGRAM | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $22,364,766 | Ends September 8, 2027 |
| 75N91021F00017ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $21,659,701.83 | Ends August 21, 2029 |
| 75N91019F00141NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT - FY19 FACILITIES TO A | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $20,958,273.07 | Ends August 29, 2025 |
| HHSN26100039IGF::OT::IGF RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $19,759,807 | Ends September 30, 2026 |
| 75N91020F00022NIAID RESEARCH DATA ECOSYSTEM FRAMEWORK (NIDEF) | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $19,667,214 | Ends May 30, 2029 |
| 75N91020F00013FY20 CONSOLIDATED FACILITIES TASK ORDER D | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $19,152,282.95 | Ends December 2, 2027 |
| 75N91021F00006FY21 CONSOLIDATED FACILITIES TASK ORDER C | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $18,374,952 | Ends September 4, 2026 |
| 75N91025F00013THE NIAID DIR FY26-27 OPERATIONAL TASK ORDER | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $17,766,274 | Ends August 30, 2027 |
| 75N91026F00032CLINICAL MATERIAL TECHNOLOGY DEVELOPMENT AND PILOT MANUFACTURING | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $17,712,309 | Ends September 23, 2031 |
| 75N91021F00010THIS TASK ORDER IS FOR THE PROTEOMIC CHARACTERIZATION LABORATORY. | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $17,159,340 | Ends September 24, 2028 |
| 75N91022F00010IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $16,869,382 | Ends July 26, 2027 |
| 75N91023F00015FY23 TASK ORDER H - 126361 WEDGEWOOD SUITE M & N EXPANSION | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $16,398,667 | Ends June 18, 2026 |
| 75N91024F00021NIAID VRC PRE-CLINICAL ASSESSMENT | Department of Health and Human ServicesNational Institutes of Health | FREDERICK, MD-06 | $16,097,583 | Ends August 31, 2031 |
Subcontracts it reported
A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.
Under award 75N91020F00003
| Subcontractor | What it is for, as reported | Amount | Date |
|---|---|---|---|
| AMERICAN TYPE CULTURE COLLECTION | MANAGEMENT OF THE NCI AT FREDERICK CENTRAL REPOSITORY LOCATIONS. | $58,553,075 | |
| THE UNIVERSITY OF CHICAGO | GDC IMPLEMENTATION | $13,219,720 | |
| THE UNIVERSITY OF CHICAGO | GDC IMPLEMENTATION | $11,610,891.33 | |
| THE UNIVERSITY OF CHICAGO | GDC IMPLEMENTATION | $11,282,154.93 | |
| ARIZONA STATE UNIVERSITY | COVID19 CBCS | $11,252,455.29 | |
| FISHER BIOSERVICES INC | PROVIDE BIOLOGICAL, CGMP CELL BANK STORAGE, ANALYTICAL SERVICES AND CLINICAL MANAGEMEN | $11,050,000 | |
| THE UNIVERSITY OF CHICAGO | GDC IMPLEMENTATION | $10,330,911.98 | |
| THE UNIVERSITY OF CHICAGO | MGMT GDC HARDWARE REFRESH | $4,114,918.01 | |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | THE OBJECTIVE IS TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING: 1) STANDARDIZATION, 2) ASSAY DEVELOPMENT, AND 3) AVAILABILITY OF LARGE-SCALE TESTING TO IDENTIFY THOSE WHO MAY HAVE BEEN INFECTED OR EXPOSED TO THE VIRUS. SCALING UP OF VALIDATED SARS-COV-2 SEROLOGICAL ASSAYS WITH EMERGENCY U | $3,463,855.17 | |
| THE UNIVERSITY OF CHICAGO | GDC HARDWARE REFRESH | $3,426,062.53 |
More subcontracts are reported under this award; the 10 largest are listed.
Under award 75N91025F00016
| Subcontractor | What it is for, as reported | Amount | Date |
|---|---|---|---|
| AMERICAN TYPE CULTURE COLLECTION | MANAGEMENT OF THE NCI AT FREDERICK CENTRAL REPOSITORY LOCATIONS. | $10,592,089 | |
| INSTITUTE FOR SYSTEMS BIOLOGY | ISB CLOUD RESOURCE | $8,550,092.64 | |
| VANDERBILT UNIVERSITY | MYC/MAX PROJECT | $4,877,124.49 | |
| THE UNIVERSITY OF CHICAGO | GDC IMPLEMENTATION | $4,840,316.50 | |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | COMPLETE THE HT-ATAC-SEQ HIGH THROUGHPUT SCREEN USING THIS ASSAY AND VALIDATE HIT MOLECULES. | $2,451,606.12 | |
| THE UNIVERSITY OF CHICAGO | GDC HARDWARE REFRESH | $969,240 | |
| FEI COMPANY | APREO CHEMISEM S LV FEG SEM | $729,938 | |
| FEI COMPANY | SERVICE MAINTENANCE CONTRACT FOR ELECTRON MICROSCOPES. | $592,675.56 | |
| PARK SYSTEMS, INC. | M-011-T-X-005 DHM-T1005 MODEL LATEST VERSION OF DHM-T1000 SERIES SINGLE WAVELENGTH TRANSMISSION CONFIGURATION INCLUDING:-- MANUAL OBJECTIVES TURRET WITH 6 POSITIONS-- LASER SOURCE MODULE 666±1 NM WITH OPTICAL FIBER COUPLING FOR ENHANCED STABILITY-- OPTICAL PATH LENGTH ADJUSTMENT FOR MULTIPLE OBJECTI | $342,159.99 | |
| EMS ACQUISITION CORP. | PP3010 CRYO-SEM/CRYO-FIB/SEM PREPARATION SYSTEM PP3010T PRESSURIZED DEWAR (60L) FOR LN2 STORAGE AND VENTING GAS SUPPLY PP7450 FOUR DAY ON SITE INSTALLATION AND CUSTOMER TRAINING PP3010T-I 12145 MICROMETER CONTROLLED FRACTURING STEEL KNIFE 13034 PFEIFFER DUO 6 ROTARY VACUUM PUMP 31370 TEM SLUSHING DE | $308,349 |
More subcontracts are reported under this award; the 10 largest are listed.
Lobbying reports and campaign receipts that name this vendor
A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.
Lobbying reports that name LEIDOS HOLDINGS, INC.
How it matched: parent company name, exact name: the name in the lobbying report as client.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| TROUTMAN STRATEGIES | LEIDOS HOLDINGS, INC. | $40,000reported as income | Third quarter of 2026 | Open the report |